Amyris IPO Raises $85M

Biochemicals start-up Amyris raised about $85 million in an IPO late last week, reports say. The company went public at $16/share, below a previously announced target of $18-$20/share. It closed at $17.23/share on Friday, October 1. The company aims to use synthetic biology to develop alternatives to petrochemicals and gasoline, but has not yet commercialized any...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers